[Cost-minimization analysis of replacement therapy in the treatment of von Willebrand disease]

by Giancarlo Castaman
Published 2016-06-01

CHANGES OF VON WILLEBRAND FACTOR DURING PREGNANCY IN WOMEN WITHOUT AND WITH VON WILLEBRAND DISEASE

by Giancarlo Castaman
Published 2013-07-01

Diagnosis and Treatment of von Willebrand Disease and Rare Bleeding Disorders

by Giancarlo Castaman, Silvia Linari
Published 2017-04-01

Albutrepenonacog alfa (Idelvion®) for the treatment of Italian patients with hemophilia B: a budget impact model

by Lorenzo Pradelli, Sara Villa, Giancarlo Castaman
Published 2018-01-01

Factors VIII and von Willebrand levels in women undergoing Assisted Reproduction: are their levels associated with clinical pregnancy outcome?

by Monica Attanasio, Michela Cirillo, Maria Elisabetta Coccia, Giancarlo Castaman, Cinzia Fatini
Published 2020-08-01

Hemophilia management: Huge impact of a tiny difference

by Fabienne Kloosterman, Anne‐Fleur Zwagemaker, Amal Abdi, Samantha Gouw, Giancarlo Castaman, Karin Fijnvandraat
Published 2020-03-01

TNF-α/TNF-R System May Represent a Crucial Mediator of Proliferative Synovitis in Hemophilia A

by Mirko Manetti, Silvia Linari, Eloisa Romano, Irene Rosa, Christian Carulli, Massimo Innocenti, Marco Matucci-Cerinic, Lidia Ibba-Manneschi, Giancarlo Castaman, Daniela Melchiorre
Published 2019-06-01